Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sarcopenic Dysphagia and Simplified Rehabilitation Nutrition Care Process: An Update.
Kakehi S, Isono E, Wakabayashi H, Shioya M, Ninomiya J, Aoyama Y, Murai R, Sato Y, Takemura R, Mori A, Masumura K, Suzuki B. Kakehi S, et al. Among authors: ninomiya j. Ann Rehabil Med. 2023 Oct;47(5):337-347. doi: 10.5535/arm.23101. Epub 2023 Oct 31. Ann Rehabil Med. 2023. PMID: 37907225 Free PMC article.
Optimal Treatment Duration of Neoadjuvant Endocrine Therapy for Women Aged 60 Years or Older with Estrogen Receptor-Positive, HER2-Negative Invasive Breast Cancer.
Hayashi Y, Takei H, Saito T, Kai T, Inoue K, Kurosumi M, Ninomiya J; Saitama Breast Cancer Clinical Study Group (SBCCSG). Hayashi Y, et al. Among authors: ninomiya j. J Nippon Med Sch. 2021 Sep 1;88(4):354-360. doi: 10.1272/jnms.JNMS.2021_88-509. Epub 2020 Nov 30. J Nippon Med Sch. 2021. PMID: 33250473 Free article.
Changing clinical and molecular characteristics of hepatitis E virus infection in Mie Prefecture, Japan: Disappearance of indigenous subtype 3e strains.
Nakano T, Okano H, Takahashi M, Nagashima S, Shiraki K, Oya Y, Inoue H, Ohmori S, Tsukimoto M, Ishida S, Fujimoto S, Kobayashi M, Yamawaki M, Kumagai M, Ninomiya J, Maegawa T, Kojima Y, Araki J, Hamaoka S, Horiike S, Yoshimura H, Takeuchi K, Itoh K, Akachi S, Uraki S, Yamamoto N, Ogura S, Sugimoto K, Yoshikawa K, Hasegawa H, Iwasa M, Takei Y, Okamoto H. Nakano T, et al. Among authors: ninomiya j. Hepatol Res. 2019 Sep;49(9):1003-1014. doi: 10.1111/hepr.13357. Epub 2019 Jun 7. Hepatol Res. 2019. PMID: 31026368
Correction to: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial.
Inoue K, Ninomiya J, Saito T, Okubo K, Nakakuma T, Yamada H, Kimizuka K, Higuchi T; SBCCSG-36 investigators. Inoue K, et al. Among authors: ninomiya j. Invest New Drugs. 2019 Jun;37(3):592-593. doi: 10.1007/s10637-019-00773-9. Invest New Drugs. 2019. PMID: 31025237 Free PMC article.
147 results